Edition:
United Kingdom

People: Yield10 Bioscience Inc (YTEN.OQ)

YTEN.OQ on NASDAQ Stock Exchange Capital Market

0.83USD
23 Aug 2019
Change (% chg)

$-0.04 (-4.57%)
Prev Close
$0.88
Open
$0.85
Day's High
$0.86
Day's Low
$0.83
Volume
7,340
Avg. Vol
30,658
52-wk High
$1.76
52-wk Low
$0.68

Brum, Lynne 

Ms. Lynne H. Brum is a Vice President - Planning and Communications of the Company. Ms. Brum has served as vice president, marketing and corporate communications, of the Company since November, 2011. Prior to joining Metabolix, in 2010 to 2011 she was a communications consultant and served in various roles including as a freelance project director for Seidler Bernstein Inc. Ms. Brum served from 2007 to 2009 as an executive vice president at Porter Novelli Life Sciences, a subsidiary of global PR firm, Porter Novelli International. Prior to that, Ms. Brum was responsible for corporate communications, investor relations and brand management for Vertex Pharmaceuticals, Inc. from 1994 to 2007 in various positions, including vice president of strategic communications. Ms. Brum was also a vice president at Feinstein Kean Healthcare and was part of the communications team at Biogen, Inc. (now Biogen Idec). Ms. Brum holds a bachelor's degree in biological sciences from Wellesley College and a master's degree in business administration from Simmons College's School of Management.

Basic Compensation

Total Annual Compensation, USD 295,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 11,700
Fiscal Year Total, USD 306,700

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --